Cancel
Known information
- Joined RAPT in September 2022
- Brings over 20 years of biopharmaceutical commercial and marketing expertise
- Most recently served as Global Commercial Lead of Dermatology at Arena Pharmaceuticals, acquired by Pfizer
- Led global commercial strategy for Etrasimod in atopic dermatitis and alopecia areata at his previous position
- Was U.S. Commercial Director of XGEVA (denosumab) at Amgen
- Held various senior marketing positions in oncology, bone health, and inflammation business units
- Earlier in his career, held various marketing positions at Pharmacia and Procter & Gamble
- Holds an M.B.A. from Rutgers University
- Holds an M.A and B.A. in Electrical Engineering from University of Cambridge
About Rapt Therapeutics
Rapt Therapeutics, headquartered in South San Francisco, develops oral therapies for inflammatory diseases and cancer, focusing on modulating the immune system through its proprietary drug discovery engine.
Report inaccurate information
